Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > Voyageur Pharmaceuticals with a "big market to go for"

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon Dec 22, 2024 11:11pm

47 Views

Post# 36374531

RE:RE:Voyageur Pharmaceuticals with a "big market to go for"

co. needs to change its plans. It was going to build an iodine line in its own GMP facility once it gets built and make iodine contrast media with imported iodine agents. I say build the iodine line now in the contract manufacturer's GMP facilty where the barium line is located and get on with getting Health Canada/FDA approvals.

<< Previous

Bullboard Posts

Next >>

Nintendo stock hits new all-time high as excitement builds over Switch successor